文献速递儿科与产科急症心脑血管急症重症综合管理与镇静镇痛

颅内高压风险神经系统疾病患儿联合使用氯胺酮

Co-administration of Ketamine in Pediatric Patients with Neurologic Conditions at Risk for Intracranial Hypertension.
PubMed 文献 · Neurocrit Care · 2022-10-08
一句话结论回顾性研究显示,对有颅内高压风险的患儿,氯胺酮作为主要诱导剂不增加围插管期神经、血流动力学或呼吸相关事件风险。

这项回顾性观察研究纳入2015至2020年一所四级儿童医院收治的143例有颅内高压风险的<18岁患儿,比较氯胺酮(70例)与其他药物作为气管插管主要诱导剂对围插管期神经、血流动力学和呼吸相关事件的影响。插管后所有患儿均接受芬太尼、咪达唑仑和/或丙泊酚等辅助镇痛镇静,剂量不足以诱导全身麻醉但可保持舒适以完成后续诊断检查。结果显示两组神经相关事件无显著差异(p=0.42),包括急诊CT(p=0.28)、插管后5小时内急诊去手术室(p=0.6)、诱导给药后15分钟内需用高渗盐水(p=0.51);2例有临床和影像学脑疝证据,氯胺酮未较其他药物产生更不利影响(p=0.49)。23例记录插管前后颅内压值,其中11例接受氯胺酮,3例颅内高压缓解或改善,其余8例颅内压正常且未被氯胺酮加重;两组整体血流动力学或呼吸相关事件无显著差异,均无24小时死亡。

要点

  • 有颅内高压风险的患儿以氯胺酮为主要诱导剂插管,神经相关事件与用其他诱导剂者无显著差异(p=0.42)。
  • 具体神经事件:急诊CT(p=0.28)、插管后5小时内急诊去手术室(p=0.6)、诱导后15分钟内用高渗盐水(p=0.51)两组均无显著差异。
  • 2例有临床和影像学脑疝证据,氯胺酮未较其他药物产生更不利影响(p=0.49)。
  • 23例有插管前后颅内压记录,其中11例用氯胺酮:3例颅内高压缓解或改善,8例颅内压正常且未被氯胺酮加重。
  • 两组整体血流动力学或呼吸相关事件无显著差异,均无24小时死亡。

适用人群与场景

  • 2015至2020年一所四级儿童医院收治的<18岁有颅内高压风险、需气管插管的患儿。

处置流程与药物剂量

  • 氯胺酮作为气管插管主要诱导剂(70例)。
  • 插管后所有患儿均接受辅助镇痛镇静药物(芬太尼、咪达唑仑和/或丙泊酚),剂量不足以诱导全身麻醉但可保持舒适以完成后续诊断检查。

研究设计与关键结果

  • 回顾性观察研究,纳入143例有颅内高压风险的患儿,其中70例以氯胺酮为主要诱导剂插管,比较氯胺酮与非氯胺酮诱导的围插管期神经、血流动力学和呼吸相关事件。
  • 神经相关事件在氯胺酮组与非氯胺酮组间无显著差异(p=0.42),包括急诊CT(p=0.28)、插管后5小时内急诊去手术室(p=0.6)、诱导给药后15分钟内需用高渗盐水(p=0.51)。
  • 2例有临床和影像学脑疝证据,氯胺酮未较其他药物产生更不利影响(p=0.49)。
  • 143例中23例有插管前后颅内压记录,其中11例接受氯胺酮:3例颅内高压缓解或改善,其余8例颅内压正常且未被氯胺酮加重。
  • 两组整体血流动力学或呼吸相关事件无显著差异,均无24小时死亡。

证据类型、等级与局限

  • 证据类型:回顾性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,对有颅内高压风险的患儿,气管插管前以氯胺酮为主要诱导剂并在插管后联合其他药物,与接受其他诱导剂者相比,不增加围插管期神经、血流动力学或呼吸相关事件风险。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Ketamine has traditionally been avoided as an induction agent for tracheal intubation in patients with neurologic conditions at risk for intracranial hypertension due to conflicting data in the literature. The objective of this study was to evaluate and compare the effects of ketamine versus other medications as the primary induction agent on peri-intubation neurologic, hemodynamic and respiratory associated events in pediatric patients with neurologic conditions at risk for intracranial hypertension.

METHODS: This retrospective observational study enrolled patients < 18 years of age at risk for intracranial hypertension who were admitted to a quaternary children's hospital between 2015 and 2020. Associated events included neurologic, hemodynamic and respiratory outcomes comparing primary induction agents of ketamine versus non-ketamine for tracheal intubation.

RESULTS: Of 143 children, 70 received ketamine as the primary induction agent prior to tracheal intubation. Subsequently after tracheal intubation, all the patients received adjunct analgesic and sedative medications (fentanyl, midazolam, and/or propofol) at doses that were inadequate to induce general anesthesia but would keep them comfortable for further diagnostic workup. There were no significant differences between associated neurologic events in the ketamine versus non-ketamine groups (p = 0.42). This included obtaining an emergent computed tomography scan (p = 0.28), an emergent trip to the operating room within 5 h of tracheal intubation (p = 0.6), and the need for hypertonic saline administration within 15 min of induction drug administration for tracheal intubation (p = 0.51). There were two patients who had clinical and imaging evidence of herniation, which was not more adversely affected by ketamine compared with other medications (p = 0.49). Of the 143 patients, 23 had pre-intubation and post-intubation intracranial pressure values recorded; 11 received ketamine, and 3 of these patients had intracranial hypertension that resolved or improved, whereas the remaining 8 children had intracranial pressure within the normal range that was not exacerbated by ketamine. There were no significant differences in overall associated hemodynamic or respiratory events during tracheal intubation and no 24-h mortality in either group.

CONCLUSIONS: The administration of ketamine as the primary induction agent prior to tracheal intubation in combination with other agents after tracheal intubation in children at risk for intracranial hypertension was not associated with an increased risk of peri-intubation associated neurologic, hemodynamic or respiratory events compared with those who received other induction agents.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Mazandi VM, Lang SS, Rahman RK, et al. Co-administration of Ketamine in Pediatric Patients with Neurologic Conditions at Risk for Intracranial Hypertension. Neurocrit Care. 2022. PMID: 36207491. doi:10.1007/s12028-022-01611-2

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。